Aurora Funds - News & Events - Aurora News

Limited Partners | Contact Us

Portfolio Company News, 2010

August 2: Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients
July 27: Therapeutic HIV vaccines show promise
July 26: Regado Biosciences Announces Publication in the American Heart Association Journal Circulation of the results of a Phase 2a Study for the REG1 Anticoagulant System in Elective Percutaneous Interventions
July 19: Data for Personalized Dendritic Cell-Based Immunotherapy Presented in Two Posters and an oral presentation at the International AIDS Conference
July 13: “Research Advances from Therapeutic HIV Vaccines and Other Immune-Based Therapies” to be Showcased at NAPWA Sponsored Community Treatment Research Forum at XVIII World AIDS Conference
July 2: METABOLON IDENTIFIES PRETERM LABOR BIOMARKERS
June 16: HyperBranch wins CE mark for Adherus spinal sealant
May 26: REGADO BIOSCIENCES, INC. CONTINUES TO EXPAND ITS PATENT PORTFOLIO BY ANNOUNCING ISSUANCE OF A NEW PATENT FOR ITS PRODUCT CANDIDATES, THE REG1 AND REG2 ANTICOAGULATION SYSTEMS
May 21: Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
May 17: Argos Therapeutics Presents Phase 2a Data for Arcelis HIV Program Demonstrating Positive Impact on Viral Diversity and Viral Load
May 13: METABOLON RELEASES POTENTIAL NONINVASIVE BIOMARKERS IDENTIFIED IN NASH STUDY
February 5: Regado seeking solution to clotting conundrum
January 13: PATENT AWARDED TO METABOLON FOR METABOLOMICS METHOD